GROUP PROFILE
Haokir Capital is a US-based proprietary capital and investment management entity established in 2025. It invests at the intersection of frontier technology, healthcare innovation, and consumer transformation.We envision a world where capital, technology, and human ingenuity converge to solve the most consequential challenges of our era — and we aim to be the investment institution that bridges these forces with discipline, integrity, and long-term purpose.
Our mission is to identify, invest in, and actively support the companies and technologies that will define the next era of human progress — while generating superior risk-adjusted returns through principled capital allocation.
Founder
Founder of Haokir Capital, Vtslx, QuantelixAI, and Gisyit Nisxty.
Exclusive fast-track for high-tech emerging enterprises. Submissions undergo a stricter review process but provide direct face-to-face communication opportunities.
yikewang@capital.haokir.comArtificial Intelligence
Agent
Aerospace
Astreus N
Biomedicine
Biocentria Holdings
Key Entities: QuantelixAI & Vtslx
Yike Wang believes in the transformative power of AI. With QuantelixAI and Vtslx, the focus is on advancing cognitive computing, deep learning algorithms, and intelligent automation to redefine productivity paradigms across global industries.
Key Entities: Vtslx & Astreus N
Pioneering the ultimate frontier. Through strategic capital deployment, Yike Wang supports ventures developing next-generation aerospace technologies, advanced propulsion systems, and sustainable commercial space exploration initiatives.
Key Entities: AevianBio
Committed to humanity’s well-being, the biomedicine focus encompasses genomic research, advanced therapeutics, and precision medicine. The objective is to tackle complex global health dilemmas by accelerating biomedical breakthroughs.
Founder
Founder of Haokir Capital, Vtslx, QuantelixAI, and Gisyit Nisxty.
Exclusive fast-track for high-tech emerging enterprises. Stricter review, but direct founder communication.
yikewang@capital.haokir.com01 — QuantelixAI & Vtslx
Yike Wang believes in the transformative power of AI. With QuantelixAI and Vtslx, the focus is on advancing cognitive computing, deep learning algorithms, and intelligent automation to redefine productivity paradigms across global industries.
02 — Vtslx & Astreus N
Pioneering the ultimate frontier. Through strategic capital deployment, Yike Wang supports ventures developing next-generation aerospace technologies, advanced propulsion systems, and sustainable commercial space exploration initiatives.
03 — AevianBio
Committed to humanity’s well-being, the biomedicine focus encompasses genomic research, advanced therapeutics, and precision medicine. The objective is to tackle complex global health dilemmas by accelerating biomedical breakthroughs.
We hold ourselves to the highest standards of professional conduct. Every decision is made with transparency, fairness, and respect for all stakeholders.
We invest with a 5–15 year horizon, resisting short-term pressures in favor of building enduring value. Patient capital is our competitive advantage.
We pursue excellence in every dimension — from investment analysis to portfolio support to institutional operations. Mediocrity is not an option.
We believe that the best outcomes emerge from genuine partnership — with founders, co-investors, advisors, and portfolio companies working as one team.
Haokir Inc. was established as a proprietary operating enterprise. The AI Application Platform project was initiated, and the Quantelix AI native framework was launched.
The Hydite project was formally initiated in February 2026 as a new full-stack AI application platform.
The Hydite ecosystem was established in March 2026, connecting its platform, applications, and operating partners.
Cauiril was formally initiated as a proprietary Agent application platform. Hydite and Cauiril officially opened their waitlist channels.
Group Headquarters
OPERATIONAL
Greater China Operations
OPERATIONAL
Investment & Research
OPERATIONAL
Southeast Asia Hub
PLANNED 2026
North America Office
PLANNED 2026
Explore partnership and investment opportunities with Haokir Capital.